CELU

NASDAQ 已收盘

Celularity

0.46 USD
▼-0.00-1.05%
盘后 0.45 -2.59%
2026-11-20
市值
$15.02M
市盈率
—
EPS
-1.63
股息率
—
52 周区间
0.42 – 2.55
成交量
295.87K
Beta
0.88
目标价
—
52W 低 0.4252W 高 2.55
价格走势

公司简介

Celularity Inc., a cellular and regenerative medicine company, focuses on addressing aging-related disease using novel therapies. The company operates through three segments: Cell Therapy, Degenerative Disease, and BioBanking. It develops off-the-shelf placental-derived allogeneic cell therapy product candidates, including mesenchymal-like adherent stromal cells for diabetic foot ulcer and Crohn’s disease. Its therapeutic programs include PDA-001 for the treatment of autoimmune (Crohn’s) and degenerative disease; and PDA-002 for treating multip...